Miromatrix to Report Second Quarter 2022 Financial Results

Rhea-AI Summary

Miromatrix Medical Inc. (NASDAQ: MIRO) will announce its second quarter 2022 financial results on August 15, 2022, after market close. A conference call is scheduled for 3:30 PM CT to discuss these results. Miromatrix focuses on bioengineering fully transplantable human organs, specifically targeting human livers and kidneys. The company utilizes a proprietary perfusion technology platform to scale organ production and address the organ shortage crisis. For more details, visit their investor relations website.

Positive

• Focus on bioengineering transplantable organs, addressing organ shortage.
• Proprietary technology platform may efficiently scale production.

Negative

• None.

EDEN PRAIRIE, Minn., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today announced that the Company will report financial results for the second quarter 2022 after market close on Monday, August 15, 2022. Company management will host a corresponding conference call beginning at 3:30 pm Central Time / 4:30 pm Eastern Time.

Individuals interested in listening to the conference call may do so by dialing 877-407-3982 for domestic callers or 201-493-6780 for international callers. Please reference Conference ID: 13730782. To listen to a live webcast, please visit the investor relations section of Miromatrix's website at: https://miromatrix.gcs-web.com/

About Miromatrix
Miromatrix Medical Inc. is a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients' lives. The Company has developed a proprietary perfusion technology platform for bioengineering organs that it believes will efficiently scale to address the shortage of available human organs. The Company's initial development focus is on human livers and kidneys. For more information, visit miromatrix.com.

Investor Contact
Greg Chodaczek
347-620-7010
ir@miromatrix.com

Media Contact:
press@miromatrix.com

FAQ

When will Miromatrix report its second quarter 2022 financial results?

Miromatrix will report its second quarter 2022 financial results after market close on August 15, 2022.

What time is the conference call for Miromatrix's financial results?

The conference call will begin at 3:30 PM Central Time on August 15, 2022.

How can I listen to Miromatrix's conference call?

You can dial 877-407-3982 for domestic calls or 201-493-6780 for international calls, or listen via the live webcast on Miromatrix's investor relations website.

What is Miromatrix's focus area in the life sciences sector?

Miromatrix focuses on bioengineering fully transplantable human organs, particularly livers and kidneys.

What technology does Miromatrix use for organ bioengineering?

Miromatrix uses a proprietary perfusion technology platform to bioengineer organs.